The Cigna Group, Leading Health Plans Advance Work to Simplify Prior Authorization

Rhea-AI Summary

The Cigna Group (NYSE:CI) joined leading health plans to standardize electronic prior authorization submission requirements for commonly reviewed medical services. By year-end, the company expects the standard approach to cover more than 70% of prior authorization volume, with additional services added on a rolling basis.

The company says this effort follows prior work that reduced medical prior authorization volume by approximately 15% and aims to accelerate real-time electronic approvals to simplify access to care for patients and reduce administrative burden for providers.

AI-generated analysis. Not financial advice.

Positive

• Standardization target: covers >70% of prior authorization volume by year-end
• Prior authorizations reduced by ~15%, easing provider paperwork
• Supports acceleration of real-time electronic approvals across plans

Negative

• Partial coverage: additional services added on a rolling basis, so not all services covered immediately

News Market Reaction – CI

-1.46%

1 alert

-1.46% News Effect

On the day this news was published, CI declined 1.46%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Standardized prior auth coverage: more than 70% of prior authorization volume Prior auth reduction: approximately 15 percent 2025 Revenue: $275 billion +5 more

8 metrics

Standardized prior auth coverage more than 70% of prior authorization volume Share of medical services under standardized electronic prior authorization by year-end

Prior auth reduction approximately 15 percent Reduction in overall medical prior authorization volume already achieved

2025 Revenue $275 billion Full-year 2025 revenue from DEF 14A, up 11%

2025 Net income $6 billion ($22.18 per share) Shareholders’ net income for 2025 from DEF 14A

Adjusted income from operations $8 billion ($29.84 per share) 2025 adjusted income from operations from DEF 14A

Capital returns 2025 $5.2 billion Dividends and buybacks returned to shareholders in 2025

Shields investment $3.5 billion Investment in Shields Health Solutions disclosed in DEF 14A

Medicare business sale $4.9 billion Sale of Medicare-related businesses to refocus on higher-growth services

Market Reality Check

Price: $285.63 Vol: Volume 1,352,935 is sligh...

normal vol

$285.63 Last Close

Volume Volume 1,352,935 is slightly below the 20-day average of 1,440,756. normal

Technical Price 279.68 is trading below the 200-day MA at 282.77, suggesting a modestly weaker longer-term trend.

Peers on Argus

CI gained 1.83% while major peers were mixed: CVS +3.63%, ELV +5.14%, CNC +3.88%...

CI gained 1.83% while major peers were mixed: CVS +3.63%, ELV +5.14%, CNC +3.88%, MOH +6.03%, and HUM -1.61%. Moves are not uniformly aligned, pointing to a stock‑specific tilt rather than a uniform sector rotation.

Common Catalyst CVS (Aetna) also issued a same‑day headline on simplifying prior authorization, indicating a coordinated industry initiative around electronic prior authorization and access to care.

Historical Context

5 past events · Latest: Apr 16 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Apr 16	Community health grants	Positive	+2.9%	Foundation opened $250,000 grant program to improve access to care.
Apr 15	Digital experience award	Positive	-1.5%	Cigna Healthcare ranked No. 1 for digital experience by JD Power.
Apr 02	Earnings call notice	Neutral	+1.0%	Announcement of Q1 2026 earnings release and conference call timing.
Mar 24	Veteran support update	Positive	+1.7%	Report on helping 8,000+ veterans with housing stability programs.
Mar 04	Credit ratings affirmed	Positive	-1.2%	AM Best affirmed key ratings at A (Excellent) with stable outlook.

Pattern Detected

Recent news skewed toward reputational and operational positives has produced mixed price reactions, with some favorable corporate developments sold into and others bid up.

Recent Company History

Over the past two months, CI’s news flow has highlighted community impact, digital leadership, ratings strength, and upcoming earnings. Foundation grant programs and veteran housing initiatives (e.g., on Mar 24 and Apr 16) coincided with gains, while accolades for digital experience and AM Best rating affirmations on Apr 15 and Mar 4 saw modest declines. The latest prior authorization streamlining continues this theme of operational simplification and access improvement, building on a series of stakeholder‑focused announcements.

Regulatory & Risk Context

Active S-3 Shelf

Shelf Active

Active S-3 Shelf Registration 2025-09-02

CI has an effective S-3ASR shelf registration filed on 2025-09-02, allowing registered securities issuance under a base prospectus. At least one takedown has occurred via a 424B5 on 2025-09-02. Terms cover various debt security features, default events, amendment mechanics, and potential defeasance provisions.

Market Pulse Summary

This announcement highlights CI’s push to simplify care access by standardizing electronic prior aut...

Analysis

This announcement highlights CI’s push to simplify care access by standardizing electronic prior authorization for medical services representing over 70% of prior authorization volume and building on a 15 percent reduction already achieved. It complements a broader story of strong 2025 financial performance and strategic portfolio reshaping. Investors monitoring this theme may focus on how quickly real-time electronic approvals scale, how providers respond operationally, and how these changes interact with CI’s broader capital deployment and debt‑issuance flexibility under its effective shelf registration.

Key Terms

prior authorization, electronic prior authorization, hhs, cms, +1 more

5 terms

prior authorization medical

"standardize electronic prior authorization submission requirements for commonly reviewed medical services"

Prior authorization is a process where a health insurance company requires approval before covering certain medical services or medications. It functions like a pre-approval step, ensuring that the treatment is necessary and appropriate before expenses are paid. For investors, understanding prior authorization is important because delays or denials can impact healthcare costs, provider operations, and the financial stability of related companies.

electronic prior authorization technical

"commitment to standardize electronic prior authorization submission requirements"

Electronic prior authorization is a digital process that lets doctors, pharmacies and insurers exchange the paperwork needed to approve coverage for a prescription or medical service before it’s provided. By replacing phone calls and faxes with automated checks and approvals, it reduces delays and administrative costs, speeding patient access to treatment. Investors care because faster, more predictable approvals can boost drug and device uptake, shrink operational expenses, and influence revenue timing for healthcare and tech companies.

hhs regulatory

"multi‑year commitments made in partnership with HHS and CMS to streamline"

The U.S. Department of Health and Human Services is the federal agency that shapes national health policy, runs major public-health programs, funds medical research and enforces health-related regulations. Its decisions act like a traffic controller for the health sector—changing rules, funding or approval pathways can speed up or block revenue and market access for hospitals, insurers, drugmakers and medical device companies, so investors watch HHS actions for potential impacts on profits and valuations.

cms regulatory

"multi‑year commitments made in partnership with HHS and CMS to streamline"

The Centers for Medicare & Medicaid Services (CMS) is the U.S. federal agency that sets rules, payment rates and coverage decisions for major public health insurance programs; think of it as both a giant insurer and the rulebook maker for how many healthcare providers and drug makers get paid by government programs. Its policy changes and reimbursement decisions can materially affect revenue, profit forecasts and valuations for hospitals, insurers, device makers and drug companies, so investors watch CMS announcements closely.

real-time electronic approvals technical

"will help support the acceleration of real-time electronic approvals"

Digital approval given instantly through an electronic system that confirms a request—such as a trade, regulatory filing, medical prescription, or workflow step—has met required checks and can proceed without manual paperwork. Think of it as an instant green light that replaces waiting for a person to sign off. Investors care because faster, automated approvals reduce delays and operational risk, speed revenue recognition and product launches, and can lower compliance costs that affect profitability.

AI-generated analysis. Not financial advice.

BLOOMFIELD, Conn., April 24, 2026 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today joined leading health plans in a commitment to standardize electronic prior authorization submission requirements for commonly reviewed medical services, a step that will accelerate patients' access to care and simplify administrative work for providers and their teams.

By the end of this year, the company expects that this standard approach will apply to medical services representing more than 70% of prior authorization volume, and additional services will be added on a rolling basis.

"We want patients to get the care they need when they need it, and we want doctors and teams to be able to focus on patients—not paperwork," said Dr. Amy Flaster, Chief Medical Officer, The Cigna Group. "We are leading much-needed improvements to make prior authorization clearer and more consistent. While this is important progress, we know there's more to do as we continue our journey to deliver a simpler, more personalized health care experience to all those we serve."

This advances the company's commitments to make care simpler and easier to navigate for patients and providers. The Cigna Group has already reduced the overall volume of medical prior authorizations by approximately 15 percent, making it easier for patients to access care and reducing paperwork for providers.

The initiative also represents the latest milestone in the health plan industry's voluntary, multi‑year commitments made in partnership with HHS and CMS to streamline and simplify the prior authorization process, and will help support the acceleration of real-time electronic approvals.  

About The Cigna Group

The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 countries and jurisdictions and has more than 185 million customer relationships around the world. Learn more at thecignagroup.com.

Media Contact:

Justine Sessions

media@cigna.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-cigna-group-leading-health-plans-advance-work-to-simplify-prior-authorization-302752909.html

SOURCE The Cigna Group

FAQ

What change did The Cigna Group (CI) announce about prior authorization on April 24, 2026?

They committed to standardize electronic prior authorization requirements for commonly reviewed services. According to The Cigna Group, the standard approach should apply to more than 70% of prior authorization volume by the end of 2026, with additional services added later.

How much has The Cigna Group (CI) reduced medical prior authorizations to date?

The company reports an approximate 15% reduction in overall medical prior authorization volume. According to The Cigna Group, that decline has reduced paperwork for providers and aimed to make it easier for patients to access care.

Will The Cigna Group (CI) enable real-time electronic approvals with this initiative?

The initiative is intended to support acceleration of real-time electronic approvals. According to The Cigna Group, standardizing submission requirements for common services will help advance real-time approval capability across plans.

When will the standardized prior authorization approach cover most services for CI members?

The company expects the standard approach to cover >70% of prior authorization volume by the end of 2026. According to The Cigna Group, additional services will be added on a rolling basis after that date.